PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.34%
Revenue growth under 50% of MCHP's 10.82%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
0.45%
Gross profit growth under 50% of MCHP's 15.09%. Michael Burry would be concerned about a severe competitive disadvantage.
-9.38%
Negative EBIT growth while MCHP is at 140.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-9.38%
Negative operating income growth while MCHP is at 132.00%. Joel Greenblatt would press for urgent turnaround measures.
-20.83%
Negative net income growth while MCHP stands at 87.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-20.00%
Negative EPS growth while MCHP is at 70.34%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-20.00%
Negative diluted EPS growth while MCHP is at 70.34%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-4.76%
Share reduction while MCHP is at 0.33%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.76%
Reduced diluted shares while MCHP is at 0.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-3.40%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
131.58%
OCF growth above 1.5x MCHP's 33.85%. David Dodd would confirm a clear edge in underlying cash generation.
319.57%
FCF growth above 1.5x MCHP's 34.43%. David Dodd would verify if the firm’s strategic investments yield superior returns.
59.17%
10Y revenue/share CAGR 1.25-1.5x MCHP's 51.09%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
38.19%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
13.96%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
168.99%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
5.29%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
-18.74%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.02%
Negative 3Y equity/share growth while MCHP is at 17.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
70.37%
Below 50% of MCHP's 175.02%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
70.37%
3Y dividend/share CAGR at 75-90% of MCHP's 81.65%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
-2.63%
Firm’s AR is declining while MCHP shows 10.99%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.72%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.81%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.09%
Positive BV/share change while MCHP is negative. John Neff sees a clear edge over a competitor losing equity.
-2.06%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
4.36%
SG&A growth well above MCHP's 4.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.